Table 1b.
AE 941 arm (n = 131) | Placebo arm (n = 128) | |
---|---|---|
Mean ± SD number of target lesions used | 2.3 ± 0.8 | 2.3 ± 0.8 |
Mean ± SD baseline tumor size (mm) | 97.1 ± 57.6 | 104.1 ± 58.9 |
RR by RECIST at 8 weeks | 2.3 % | 0.8% |
Mean ± SD % change in tumor size at 8 weeks vs. baseline | 13.0% ± 27.9% | 16.2% ± 22.1% |
Mean log ratio ± SD of tumor size at 8 weeks vs. baseline | 0.10 ± 0.22 | 0.13 ± 0.18 |